Neurotop® contains the active substance carbamazepine.
Carbamazepine has both a seizure-inhibiting and a mood-improving effect in various forms of epileptic seizures.
Neurotop® is given to adults, children and adolescents for the treatment of epilepsy.
Neurotop® can be used for monotherapy and combination therapy.
Neurotop® is used in adults for the treatment of acute mania and for the phase prophylaxis of manic-depressive psychoses in patients who do not respond to or for whom lithium therapy is contraindicated. Neurotop® is also used in trigeminal neuralgia, diabetic neuropathy and to prevent cerebral seizures in alcohol withdrawal syndrome.
Strength | Pack size | Dosage form | Appearance |
200 mg | 50, 100 | Tablets |
![]() |
400 mg | 50, 100 | Tablets |
![]() |
300 mg | 100 | Prolonged-release tablets |
![]() |
600 mg | 100 | Prolonged-release tablets |
![]() |